Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen EZ2 Connect MDx

Qiagen has launched the EZ2 Connect MDx system for clinical use. The automated sample processing system was previously available for research use. It uses pre-filled, sealed reagent cartridges and bead-based technology to purify RNA and DNA from blood plasma, serum, stool, or other sample types. The system can process 24 samples in parallel in approximately 30 minutes. It can be used in research mode or in a dedicated IVD mode and can access the QIAsphere digital laboratory ecosystem, which enables full integration into the digital infrastructure of a lab and remote instrument management. EZ2 Connect MDx is CE-IVD marked and available in the US, Canada, and other countries.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.